Evidence map›Paper›PMID 40430090›Full record

ArticleInternational journal of molecular sciences2025

Controlled Exit from the G2/M Checkpoint in RPE-1 Cells Using RO3306: Enrichment of Phase-Specific Cell Populations for In-Depth Analyses of Mitotic Events.

Teresa Anglada, Núria Pulido-Artola, Marina Rodriguez-Muñoz, Anna Genesca

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Teresa AngladaDepartment of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Núria Pulido-ArtolaDepartment of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Marina Rodriguez-MuñozDepartment of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.ORCID 0000-0002-1658-2493
Anna GenescaDepartment of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.

Funding

Consejo de Seguridad Nuclear CSN-2020-01Generalitat de Catalunya 2021-SGR-122Generalitat de Catalunya FI-SDUR-2022-00237La Marató de TV3 Foundation 201918-30
6 · The paper itself

Abstract

Studying the cell cycle is essential for understanding the molecular mechanisms that regulate cell division, growth, and differentiation in living organisms. However, mitosis constitutes only a brief phase of the overall cell cycle, making its analysis challenging in asynchronous cell populations due to its transient and dynamic nature. Cell synchronization methods help to enrich populations at specific cell cycle stages, including mitosis, typically by using chemical inhibitors to arrest cells at defined checkpoints. However, many existing protocols rely on combinations of inhibitors that interfere with normal mitotic progression, disrupting dynamics and causing side effects such as chromosome non-disjunction or lagging chromosomes, which limit their applicability. In this study, we present an RO3306 block-and-release strategy to selectively enrich cell populations at defined mitotic stages without compromising cell viability or disrupting their progression to mitotic exit. This approach provides a reliable method for studying mitotic events with high temporal resolution. Furthermore, by preserving mitotic integrity, it offers a valuable framework for investigating the molecular mechanisms of cell division and the processes driving genomic instability in human cells.

Indexed as

G2 Phase Cell Cycle CheckpointsMitosisM Phase Cell Cycle CheckpointsRetinal Pigment EpitheliumCell LineHumanscell cyclecell divisionmitosisRO3306synchronization

Identifiers

PMID40430090
PMCPMC12112338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.